Evidence map›Paper›PMID 42440531›Full record

ArticleFrontiers in physiology2026

Association of high-sensitivity C-reactive protein and lipoprotein-associated phospholipase A

Shi-Ning Luo, Xiang-Yi Guo, Qing-Li Liu, Zhi-Juan Li

Abstract read
In one paragraph

Article in Frontiers in physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Shi-Ning Luo *Department of Cardiology, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, China.
Xiang-Yi Guo *Department of Cardiology, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, China.
Qing-Li LiuDepartment of Cardiology, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, China.
Zhi-Juan LiDepartment of Cardiology, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To evaluate the associations of high-sensitivity C-reactive protein (hs-CRP) and lipoprotein-associated phospholipase A Methods: A total of 438 hospitalized patients who underwent coronary angiography in the Department of Cardiology of the First Affiliated Hospital of Henan University of Science & Technology between April 2023 and April 2024 were retrospectively analyzed. Based on the extent of coronary artery stenosis, participants were divided into a CHD group (stenosis ≥50%, n = 329) and a control group (stenosis <50%, n = 109). General clinical data and laboratory indicators, including Lp-PLA Results: Serum levels of both Lp-PLA Conclusion: The combined evaluation of Lp-PLA

Indexed as

coronary atherosclerotic heart diseaseGensini scorehigh-sensitivity C-reactive proteinHs-CRPlipoprotein-associated phospholipase A2Lp-PLA2

Identifiers

PMID42440531
PMCPMC13333470

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.